[ad_1]
The European Medicines Agency EMA wants to decide on the approval of another crown vaccine on January 6. It is about the preparation of the American manufacturer Moderna, as announced by the authority in Amsterdam. That’s six days earlier than originally planned.
The Moderna vaccine could therefore be the second most likely to hit the EU market. The EMA wants to decide on Monday on the approval of the vaccine by the manufacturers Pfizer and Biontech. As soon as the EU Commission gives the green light, vaccinations could be carried out in the EU from December. The approval of the Commission is a matter of form.
The EMA had previously stated that it would decide on the Moderna vaccine on January 12. The drug company sent the latest data packet on Thursday, earlier than expected. This contains information specific to production for the EU market ”, announced the authority. In the scientific evaluation of all the data and studies, however, no compromises are made in terms of safety and efficacy.
Meanwhile, a US FDA advisory group on Thursday discussed the request for emergency approval for the Moderna vaccine. Scientists, doctors and employees of authorities and pharmaceutical companies discussed various aspects of the preparation, its effectiveness and side effects for different population groups through a video link.
At the end of the full-day session, a recommendation to the FDA was expected on whether the vaccine should receive emergency approval in the US The final decision is then left to the FDA and expected shortly after the meeting ended . US government officials had already announced that vaccines could begin early next week after an emergency approval.
